NAPRT and cancer: Additionally, cancer cell lines with low expression of NAPRT allowed for high dose treatment of FK866 and in vivo rescue of xenografted mice with nicotinic acid, the precursor to NAD biosynthesis via NAPRT (see S1 Fig), without sacrificing the therapeutic potential [9].